AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Mgraft S 360mg Tablet

Prescription Icon
Prescription Required

Marketer

Advaith Life Sciences Pvt Ltd

Salt Composition

Mycophenolate sodium (360mg)

Overview Mgraft S 360mg Tablet

Mycophenolate mofetil 360mg tablets (Mgraft S equivalent) are immunosuppressants, prescribed alongside other medications to prevent organ rejection post-transplant (kidney, heart, liver, etc.). Their mechanism involves suppressing the immune system to avoid attacking the transplanted organ. Dosage varies depending on the transplant type; strictly adhere to your physician's instructions. This medication can be taken with or without food; swallow whole – do not crush, chew, or break. Consistent use is crucial for optimal efficacy; discontinuation increases rejection risk. Treatment duration is determined by your need for rejection prevention. Common side effects include nausea, vomiting, diarrhea, abdominal pain, headache, hypertension, and altered white blood cell counts. Immunosuppression elevates infection susceptibility and cancer risk. A comprehensive list of potential side effects exists; consult your doctor regarding these, noting that some require immediate medical attention. This medication can cause birth defects and miscarriage; avoid use during pregnancy, planned pregnancy, or breastfeeding. Discuss its use with your doctor if you have infections, unusual bleeding or bruising, or a history of digestive issues. Inform your doctor of all other medications you're taking due to potential interactions. Regular blood tests will monitor blood cell counts. Report unexplained bruising, bleeding, sore throat, mouth sores, or fever immediately.

Uses of Mgraft S 360mg Tablet

Preventing graft rejection in recipients of organ transplants

Major Benefits of Mgraft S 360mg Tablet:

Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mgraft S 360mg Tablets can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Mgraft S 360mg Tablet:

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain
  • Headache
  • High blood pressure
  • Decreased white blood cell count (neutrophils)
  • Bacterial infection
  • Fungal infection
  • Pneumonia
  • Increased uric acid level in blood
  • Electrolyte imbalance
  • Anxiety
  • Breathlessness
  • Increased creatinine level in blood
  • Anemia (low number of red blood cells)
  • Acne
  • Muscle pain

How to use Mgraft S 360mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 360mg Mgraft S Tablet whole; avoid crushing, chewing, or breaking it. While food is not required, consistent timing of administration is recommended.

How Mgraft S 360mg Tablet works:

Immunosuppressant Mgraft S 360mg tablets work by dampening the body's natural immune response, thereby minimizing the risk of organ transplant rejection.

SAFETY ADVICE

AlcoholAlcoholSAFE

Ingestion of alcohol alongside Mgraft S 360mg Tablet presents no known adverse reactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Mgraft S 360mg tablets during pregnancy poses a confirmed risk to the fetus, rendering it inadvisable. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the hazards. Physician consultation is essential.

Breast feedingBreast feedingUNSAFE

The medication Mgraft S 360mg Tablet is contraindicated during lactation due to potential infant toxicity.

DrivingDrivingSAFE

Driving ability is typically unaffected by Mgraft S 360mg Tablet.

KidneyKidneyCAUTION

Individuals with severe kidney impairment should exercise caution when using Mgraft S 360mg tablets. Dosage modification may be necessary; physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

Use of the 360mg Mgraft S tablet in patients with liver disease appears to present a low risk. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.

What if you forget to take Mgraft S 360mg Tablet :

Should you forget to take a Mgraft S 360mg Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Mgraft S 360mg Tablet

LabelValue
Type of Compound Isobenzofuranone derivative
Potential for Dependence None.
Medication Classification Cancer-fighting drugs
Mechanism of Action Drugs suppressing the immune system: Purine-based medications

FAQs on Mgraft S 360mg Tablet

Mycophenolate mofetil 360mg tablets function as an immunosuppressant medication. This prescription aims to facilitate your body's acceptance of the transplanted kidney. The medication achieves this by modulating your immune system's response, suppressing the rejection of foreign tissue. Consequently, the transplanted organ is better tolerated by your body.
Taking Mgraft S 360mg tablets may elevate the risk of developing certain cancers, including skin cancer and lymphoma. Minimize sun exposure when outdoors, use protective clothing, and apply sunscreen. Consult your physician immediately if you notice any new skin lesion, a mole changing in size or color, a dark, irregularly shaped skin sore, an asymmetrical skin sore, unusual skin alterations, non-healing sores, unexplained fever, persistent fatigue, weight loss, or pain/swelling in the lymph node areas (neck, groin, or armpits).
Mgraft S 360mg tablets are not a steroid or chemotherapeutic agent. This immunosuppressant medication works by dampening the immune system's response, preventing rejection of transplanted organs. Hair loss is a frequently observed adverse effect.
Prior to commencing treatment with Mgraft S 360mg Tablet, a blood test will be necessary as this medication can influence blood cell levels and potentially impact kidney and liver function. Continued monitoring throughout the treatment period will involve regular blood tests to detect any hematological alterations. These tests are crucial for evaluating treatment efficacy and identifying potential adverse reactions.
Mgraft S 360mg tablets suppress the immune system. Because your immunity is compromised, exposure to individuals with chickenpox or shingles increases your risk of contracting these diseases. Your physician's cautionary advice stems from this risk. Consequently, adhere to your doctor's instructions and promptly seek medical attention should you exhibit symptoms of chickenpox or shingles, as specialized care may be necessary.
Avoid Mgraft S 360mg Tablet if pregnant or planning pregnancy. First-trimester use carries a significant miscarriage risk and potential birth defects. Consequently, employ two reliable contraceptive methods concurrently for four weeks pre-treatment, throughout treatment, and for six weeks post-treatment. Your physician will recommend suitable options. Note that Mgraft S 360mg Tablet can reduce the efficacy of oral contraceptives, necessitating a secondary contraceptive method.
Contraceptive measures, using a reliable method, are advised for either the male patient or his partner throughout the treatment period and for three months afterward. Male patients should refrain from donating semen during and for three months after completing treatment with Mgraft S 360mg Tablet.
Mgraft S 360mg Tablet
731
MRP 890
17% off